Melanoma/Skin Cancer News

Melanocytic lesions in the lower extremities that are marked by peripheral globules should be closely watched for melanoma development, according to a study.

Results from a quality-improvement study showed that primary care-based melanoma screening correlated with an increased detection of thin melanoma, according to data published in JAMA Dermatology.

If current trends continue, melanoma-associated mortality rates may increase by nearly 70% by 2040, according to a study.

Although much remains unknown about the impact of COVID-19 on people with cancer, the impact on screening is becoming clearer.

Use of an immune checkpoint inhibitor within 90 days of radiation therapy did not increase risk for serious adverse events among patients with cancer, according to a pooled analysis of prospective trial data published in JAMA Oncology.

A wait time of at least 20 days to undergo elective, low-risk, cancer-related surgery appeared safe following recovery from mild to moderate COVID-19, according to study results published in Annals of Surgical Oncology.

BOSTON — An increase in immune checkpoint proteins was observed in metastatic melanoma patients treated with topical diphencyprone, according to a study presented at the American Academy of Dermatology Annual Meeting.

Steven A. Rosenberg, MD, PhD, FAACR, will receive this year’s Pezcoller Foundation-American Association of Cancer Research International Award for Extraordinary Achievement in Cancer Research.

Trends in melanoma diagnosis and mortality suggest that white individuals in the United States were over-diagnosed with the disease, according to a study.

The University of Texas MD Anderson Cancer announced Thursday the launch of the James P. Allison Institute, a research and innovation hub that integrates immunobiology across disciplines to accelerate discoveries toward cancer cures.